Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The firm is also involved in developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, traumatic brain injury, and for daily health. The company was founded on August 6, 2007 and is headquartered in Elk, ID.
No Data
No Data